Abstract

3D optical reconstruction of in-vitro Glioblastoma brain tumors was evaluated longitudinally with Mesoscopic Fluorescence Molecular Tomography. Tumor response to the Temozolomide, a clinical drug, were evaluated through volumetric change.

© 2016 OSA

PDF Article